We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hemogenyx Pharmaceuticals Plc | LSE:HEMO | London | Ordinary Share | GB00BYX3WZ24 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
-0.023 | -1.43% | 1.585 | 1.57 | 1.60 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
1.60 | 1.56 | 1.60 | 5,559,012 | 16:35:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.98M | -0.0035 | -4.51 | 18.04M |
Date | Time | Source | Headline |
---|---|---|---|
25/4/2024 | 12:19 | ALNC | EARNINGS: LSL starts 2024 "strongly"; Focusrite maintains payout |
25/4/2024 | 07:00 | UK RNS | Hemogenyx Pharmaceuticals PLC Final Results |
28/3/2024 | 07:00 | UK RNS | Hemogenyx Pharmaceuticals PLC Total Voting Rights |
29/2/2024 | 14:04 | ALNC | Hemogenyx Pharmaceuticals raises money for leukaemia treatment |
29/2/2024 | 07:00 | UK RNS | Hemogenyx Pharmaceuticals PLC Placing to Raise US$4.2 million |
16/2/2024 | 11:27 | ALNC | Hemogenyx shares rise on potential for CBR to treat brain diseases |
16/2/2024 | 07:00 | UK RNS | Hemogenyx Pharmaceuticals PLC CBR Brain Delivery |
14/2/2024 | 10:14 | ALNC | Hemogenyx says CBR can be used intranasally to treat viral infections |
14/2/2024 | 07:00 | UK RNS | Hemogenyx Pharmaceuticals PLC CBR Intranasal Delivery |
09/2/2024 | 10:00 | ALNC | IN BRIEF: Hemogenyx shares surge as FDA lifts Hemo-Car-T trial hold |
1 Year Hemogenyx Pharmaceuticals Chart |
Intraday Hemogenyx Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions